Both Novo Nord's Dual GIP/GLP-1 and copyright are new medications intended for addressing hyperglycemia and supporting weight reduction . However, they work through slightly different processes . https://retatrutidevssemaglutide053759.blog-gold.com/59894034/retatrutide-vs-semaglutide-a-comparative-analysis